Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism.
OBJECTIVE
In contrast to that in patients with primary hyperparathyroidism, the value of intraoperative intact parathyroid hormone (iPTH) measurement is still unclear in patients with renal hyperparathyroidism and was, therefore, evaluated in a large cohort of patients.


METHODS
Intraoperative iPTH measurement was performed in 153 patients with renal hyperparathyroidism (129 with terminal renal failure and 24 with functioning kidney graft). Subtotal and total parathyroidectomy were performed in 123 and 13 patients, respectively, during initial surgery. In patients with recurrent disease (17), the respective hyperfunctioning tissue was removed. Intraoperative blood samples were obtained by puncture of the internal jugular vein before preparation of the parathyroids (PTH0) and 15 min after parathyroidectomy (PTH15). iPTH was measured with the Elecsys 2010 system. Postoperative iPTH levels (PTH(post)) were determined at postoperative days 1 to 3 and at week 2. Patients were arbitrarily divided in four groups according to the postoperative iPTH values: 0-25 pg/ml (group 1), 26-65 pg/ml (group 2), 66-150 pg/ml (group 3) and more than 150 pg/ml (group 4).


RESULTS
The mean PTH0 value was 869+/-57 pg/ml, which decreased to 167+/-15 pg/ml at PTH15. The mean relative PTH15 value was 21.6+/-1.7%. Postoperatively, iPTH decreased to 42+/-9 pg/ml. The postoperative iPTH value of the 129 patients with terminal renal failure was 25 pg/ml or less in 99 patients, 26-65 pg/ml in 11 patients, 66-150 pg/ml in eight patients and higher than 150 pg/ml in 11 patients. Two successive criteria of iPTH decrease were used: first, a PTH15 of < or =150 pg/ml or, second, a relative PTH15 of < or =30% less was used. Fifteen patients did not fulfil both criteria. In 13 of them (86.7%) iPTH(post) was higher than 65 pg (true failure to decline). Of 114 patients who fulfilled the criteria, 108 (94.7%) had normal postoperative iPTH values (true decline). Absolute PTH15 values of less than 150 pg/ml predicted normal postoperative iPTH levels in 77 of 78 patients.


CONCLUSIONS
A PTH15 value of 150 pg/ml or less predicts operative success in patients with renal failure in 98.7% of cases, independently of the relative decay. In contrast, if the relative PTH15 is higher than 30%, high postoperative PTH values are predicted with a probability of 86.7%. Although there remain some borderline cases, intraoperative iPTH measurement is accurate and also can be useful in patients with renal hyperparathyroidism.
Seehofer
Daniel
D
Department of General, Visceral and Transplant Surgery, Charité Campus Virchow, Humboldt University of Berlin, Berlin, Germany. daniel.seehofer@charite.de
Rayes
Nada
N
Klupp
Jochen
J
Steinmüller
Thomas
T
Ulrich
Frank
F
Müller
Christian
C
Schindler
Ralph
R
Frei
Ulrich
U
Neuhaus
Peter
P
D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood* / Q000601:surgery*; D006801:Humans; D007432:Intraoperative Period; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D016105:Parathyroidectomy; D011184:Postoperative Period; D011237:Predictive Value of Tests; D011379:Prognosis; D016896:Treatment Outcome
D010281:Parathyroid Hormone
Langenbecks Arch Surg. 1999 Dec;384(6):556-62
10654271
J Am Coll Surg. 2000 Dec;191(6):613-8
11129809
World J Surg. 1996 Sep;20(7):835-9; discussion 839-40
8678959
World J Surg. 1992 Jul-Aug;16(4):570-5
1329362
J Clin Endocrinol Metab. 1999 Nov;84(11):4287-90
10566687
Chirurg. 2002 Mar;73(3):211-6
11963493
J Clin Endocrinol Metab. 1996 Nov;81(11):3923-9
8923839
Surgery. 2000 Dec;128(6):1029-34
11114639
Ann Surg. 2002 Jul;236(1):105-11
12131092
Arch Pathol Lab Med. 2003 Nov;127(11):1424-42
14567726
Arch Pathol Lab Med. 2002 Sep;126(9):1045-9
12204053
Clin Lab. 2000;46(5-6):295-9
10853240
J Clin Invest. 1981 Mar;67(3):885-92
7204561
Ann Surg. 1999 Sep;230(3):382-8; discussion 388-91
10493485
Surgery. 2004 Feb;135(2):149-56
14739849
Surgery. 2003 Dec;134(6):973-9; discussion 979-81
14668730
Chirurg. 2001 May;72(5):578-83
11383071
Am J Surg. 1991 Oct;162(4):299-302
1683177
Arch Surg. 2001 Jul;136(7):810-6
11448396
Langenbecks Arch Surg. 2001 Nov;386(6):440-3
11735018
Clin Chem. 1998 Apr;44(4):805-9
9554492
Mayo Clin Proc. 1994 Jun;69(6):532-7
8189758
Am J Surg. 2002 Dec;184(6):578-81; discussion 581
12488174
Surgery. 1988 Dec;104(6):1121-7
3194839
J Clin Endocrinol Metab. 1998 Nov;83(11):3852-6
9814457
Eur J Endocrinol. 2002 Jun;146(6):783-8
12039698
Ann Surg. 1994 May;219(5):574-9; discussion 579-81
8185406